Website
https://www.ecor1cap.com
Industry
6630 Fund management
Business classification
Financials

VCID: 14398067
Profile

Corporate information


Registration country
Investment activity status
Active investor

Company type

Biotech-focused investment firm.

Selected investments

Country Date Notes
Ajax Therapeutics Inc
Blood cancer biotech. 		United States 13 May 2024 Series C
Follow-on investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.